07.11.2011 – 14:28

Marseille-Kliniken AG

EANS-News: Marseille-Kliniken AG improves its earnings in first quarter 2011/2012

--------------------------------------------------------------------------------
  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
Financial Figures/Balance Sheet/Preliminary quarterly results

Subtitle: - EBIT improved by 50.0 percent to EUR 3.0 million
- Revenues stable at EUR 48.2 million
- Substantial EBIT increase in the current financial year expected

Hamburg (euro adhoc) - 7 November 2011 - Marseille-Kliniken AG reported a
substantial rise in profitability in the first quarter of the 2011/2012
financial year (1 July through 30 September 2011). According to the preliminary
figures, EBIT rose by 50.0 percent to EUR 3.0 million (previous year: EUR 2.0
million). The occupancy rate rose to 88.5 percent in the first quarter of
2011/2012 after an average of 87.1 percent in the past financial year. Revenues
at EUR 48.2 million (previous year: EUR 49.1 million) remained at a stable
level. "Earnings in the first quarter 2011/2012 showed that the Group's
strategic reorientation is taking hold and profitability could be clearly
improved. We expect this development to stabilise in the whole financial year,"
says Michael Thanheiser, chairman of Marseille-Kliniken AG.

In the lapsed 2010/2011 financial year, Marseille-Kliniken AG reinforced its
focus towards the core competencies in inpatient and outpatient care for the
elderly, strengthened its quality leadership, and introduced a new,
decentralised management structure. Moreover a programme carried out to optimise
costs also played a role in supporting the company's economic recovery. In
connection with this, the company broke even in the first quarter of 2011/2012
with the construction of AMARITA Hamburg-Mitte, amongst other factors.
Marseille-Kliniken AG operates a total of 60 care facilities across Germany,
with a sales capacity of 7,960 beds.

Against the backdrop of the first quarter results, Marseille-Kliniken AG has
confirmed its forecast for the 2011/2012 financial year, which calls for Group
EBIT well above the previous year's level with a revenue increase. The
optimisation of the core business of nursing care and the improvement in
financing will remain the strategic focus here.

As announced, Marseille-Kliniken AG began the issuance of a bond for up to EUR
15.0 million on 31 October 2011. This is offered to German and European
institutional investors in the scope of a private placement. The bond has a term
of two years as well as an interest rate of 9.5 percent in the first year and
12.5 percent in the second year. It can be repaid in full after the first year.

Marseille-Kliniken AG will release the full results for the first quarter of the
2011/2012 financial year on 16 November 2011. The corresponding quarterly report
will then be made available to the public on the company's website at
www.marseille-kliniken.com.


Further inquiry note:
Christian Hillermann
Hillermann Consulting
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Germany
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114
www.marseille-kliniken.com

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


company:     Marseille-Kliniken AG
             Alte Jakobstraße 79/80
             D-10179 Berlin
phone:       +49 (0)30 246 32-400
FAX:         +49 (0)30 246 32-401
mail:         info@marseille-kliniken.de
WWW:         http://www.marseille-kliniken.de
sector:      Pharmaceuticals
ISIN:        DE0007783003
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
             Stuttgart, Düsseldorf, regulated dealing: Hamburg 
language:   English